GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05913388 · RECRUITING
Trial details
- NCT number
- NCT05913388
- Sponsor
- Providence Health & Services
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2028-02-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.